Literature DB >> 12003327

Dietary L-carnitine increases plasma insulin-like growth factor-I concentration in chicks fed a diet with adequate dietary protein level.

K Kita1, S Kato, M Amanyaman, J Okumura, H Yokota.   

Abstract

1. The effect of L-carnitine supplemented into experimental diets with varying dietary protein concentrations (50, 200 and 400 g/kg) on body weight gain and plasma insulin-like growth factor-I (IGF-I) concentration in chicks was examined. 2. Dietary L-carnitine supplementation provided 0, 200, 500 and 1000 mg/kg. Chicks were given the diet ad libitum for 10 d. 3. When L-carnitine was provided as 500 or 1000 mg/kg, body weight gain was significantly improved in birds receiving the 200 and 400 g protein/kg diets. 4. There was an interaction between dietary L-carnitine and protein content on plasma IGF-I concentration. L-carnitine supplementation had little influence on plasma IGF-I concentrations in birds receiving the low protein (50 g/kg) diet. When dietary L-carnitine concentrations were increased from 0 to 1000 mg/kg in the adequate protein (200 g/kg) diet, plasma IGF-I concentrations were also increased. However, when dietary L-carnitine content was more than 500 mg/kg in the 400 g/kg protein group, plasma IGF-I concentration decreased with increasing dietary L-carnitine content. 5. Body weight change correlated significantly with the alteration in plasma IGF-I concentrations in chicks given diets with adequate dietary protein. 6. In conclusion, the improvement in body weight gain caused by dietary L-carnitine supplementation was achieved when chicks were given their dietary protein requirement, which may be partially explained by an increase in plasma IGF-I concentration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003327     DOI: 10.1080/00071660120109980

Source DB:  PubMed          Journal:  Br Poult Sci        ISSN: 0007-1668            Impact factor:   2.095


  6 in total

Review 1.  Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2011-12-02       Impact factor: 5.614

Review 2.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

3.  Supplemental carnitine affects the microRNA expression profile in skeletal muscle of obese Zucker rats.

Authors:  Janine Keller; Robert Ringseis; Klaus Eder
Journal:  BMC Genomics       Date:  2014-06-21       Impact factor: 3.969

4.  Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions.

Authors:  Anna Montesano; Pamela Senesi; Livio Luzi; Stefano Benedini; Ileana Terruzzi
Journal:  Oxid Med Cell Longev       Date:  2015-03-08       Impact factor: 6.543

5.  Systemic regulation of L-carnitine in nutritional metabolism in zebrafish, Danio rerio.

Authors:  Jia-Min Li; Ling-Yu Li; Xuan Qin; Li-Jun Ning; Dong-Liang Lu; Dong-Liang Li; Mei-Ling Zhang; Xin Wang; Zhen-Yu Du
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

6.  Supplementation of carnitine leads to an activation of the IGF-1/PI3K/Akt signalling pathway and down regulates the E3 ligase MuRF1 in skeletal muscle of rats.

Authors:  Janine Keller; Aline Couturier; Melanie Haferkamp; Erika Most; Klaus Eder
Journal:  Nutr Metab (Lond)       Date:  2013-03-15       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.